SUVRETTA CAPITAL MANAGEMENT, LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$20,416,415
-25.4%
5,883,6930.0%1.10%
-24.6%
Q2 2023$27,359,172
+4.1%
5,883,693
+3.4%
1.46%
+31.8%
Q1 2023$26,283,577
-41.5%
5,689,086
+2.2%
1.11%
-41.2%
Q4 2022$44,966,000
+61.4%
5,565,099
+10.9%
1.89%
+63.3%
Q3 2022$27,861,000
+15.1%
5,020,000
+8.1%
1.16%
+25.8%
Q2 2022$24,200,000
-21.1%
4,645,000
+24.5%
0.92%
-1.8%
Q1 2022$30,680,000
-15.4%
3,732,400
+53.1%
0.94%
+33.5%
Q4 2021$36,274,000
-14.0%
2,437,795
+9.1%
0.70%
-1.3%
Q3 2021$42,194,000
+32.3%
2,233,695
+30.2%
0.71%
+49.1%
Q2 2021$31,889,000
+9.0%
1,715,381
+33.5%
0.48%
+10.2%
Q1 2021$29,246,000
+30.1%
1,284,976
+24.1%
0.43%
+34.9%
Q4 2020$22,479,000
+91.1%
1,035,409
-11.5%
0.32%
+51.4%
Q3 2020$11,760,000
+67.9%
1,170,166
+29.6%
0.21%
+40.4%
Q2 2020$7,006,000
+748.2%
902,800
+1014.6%
0.15%
+586.4%
Q1 2020$826,00081,0000.02%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders